Inventurus Knowledge Solutions Limited — Investor Meet, 11-08-2026: Analysts/Institutional Investor Meet/Con. Call Updates

IKS Health reported strong Q1 FY27 results: Revenue at INR 893 Cr (+21% YoY, 12% CC), adjusted EBITDA 35% (INR 314 Cr), PAT INR 193 Cr (+28% YoY). Notable client wins include a large California health system and expanded Advocate Health partnership. The TruBridge acquisition closed, adding INR 650 Cr annual EBITDA. Management targets INR 3,000 Cr EBITDA by FY30 without dilution, leveraging technology and offshore integration. The company focuses on building an integrated "new operating system for healthcare" with proprietary AI. Management expresses a confident outlook despite increasing competitive intensity.